眼高壓治療市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、給藥途徑、配銷通路、地區和競爭細分，2020-2030 年

2024 年全球眼高壓治療市場價值為 36.7 億美元，預計在預測期內將經歷強勁成長，到 2030 年的年複合成長率(CAGR) 為 3.82%。近年來，受眼高壓盛行率上升和對先進治療方案的需求不斷增加的推動，該市場取得了顯著發展。眼高壓的特徵是眼壓升高，如果不及時治療，會導致青光眼——世界範圍內不可逆失明的主要原因之一。因此，眼高壓治療市場是眼科保健領域的重要部分。例如，2024 年 1 月，印第安納大學醫學院的研究人員啟動了一項創新計劃，旨在開發突破性的青光眼治療方法，該計劃得到了美國國家眼科研究所 200 萬美元 R01 資助。

主要市場促進因素：

人口老化

主要市場挑戰：

診斷不足和缺乏認知

主要市場趨勢：

微創手術技術

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第4章：全球眼高壓治療市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按類型（眼壓過高、青光眼）
  • 依給藥途徑（口服、腸胃外、其他）
  • 按配銷通路（零售藥局、網路藥局、其他）
  • 按地區
  • 按公司分類（2024）
• 市場地圖
  • 按類型
  • 依給藥途徑
  • 按配銷通路
  • 按地區

第 5 章：亞太地區眼高壓治療市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按類型
  • 依給藥途徑
  • 按配銷通路
  • 按國家
• 亞太地區：國家分析
  • 中國
  • 印度
  • 澳洲
  • 日本
  • 韓國

第6章：歐洲眼高壓治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 西班牙
  • 義大利
  • 英國

第 7 章：北美眼高壓治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 墨西哥
  • 加拿大

第 8 章：南美洲眼高壓治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 9 章：中東和非洲眼高壓治療市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 10 章：市場動態

• 驅動程式
• 挑戰

第 11 章：市場趨勢與發展

• 最新動態
• 產品發布
• 合併與收購

第 12 章：全球眼高壓治療市場：SWOT 分析

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Angelini Spa
• Laboratorios Sophia
• Neurim Pharmaceuticals Ltd
• Nicox SA
• Novartis AG.
• Aerie Pharmaceuticals, Inc.
• Abbvie, Inc
• Angelini Pharma Spa
• Chong Kun Dang pharmaceutical Corp
• Lee Pharma Ltd

第 15 章：策略建議

第16章調查會社について,免責事項

The global Ocular Hypertension Treatment Market was valued at USD 3.67 billion in 2024 and is projected to experience robust growth during the forecast period, with a compound annual growth rate (CAGR) of 3.82% through 2030. The market has seen significant development in recent years, driven by the rising prevalence of ocular hypertension and the increasing demand for advanced therapeutic solutions. Ocular hypertension is characterized by elevated intraocular pressure, which, if left untreated, can lead to glaucoma-one of the leading causes of irreversible blindness worldwide. As a result, the ocular hypertension treatment market is a critical segment of the ophthalmic healthcare sector. For example, in January 2024, researchers at Indiana University School of Medicine launched an innovative initiative to develop groundbreaking therapy for glaucoma, supported by a USD 2 million R01 grant from the National Eye Institute.

Key Market Drivers:

Aging Population

The growing aging population is a key driver of the expanding global ocular hypertension treatment market. As individuals age, they become more susceptible to ocular hypertension due to age-related changes in the eye's drainage system, which can hinder the flow of aqueous humor and increase intraocular pressure. The World Health Organization forecasts that the global population aged 60 and older will more than double by 2050, reaching nearly 2.1 billion people. This demographic shift will result in a rise in the prevalence of ocular hypertension and glaucoma among the elderly, creating a larger patient base in need of treatment. As the population ages, there will be an increased demand for both pharmaceutical and surgical interventions, including minimally invasive procedures like Micro-Invasive Glaucoma Surgery (MIGS). These treatments offer less invasive and more efficient solutions for managing intraocular pressure. Consequently, the global ocular hypertension treatment market is positioned for steady growth, catering to the rising healthcare needs of older individuals and contributing to better vision preservation and reduced blindness rates.

Key Market Challenges:

Underdiagnosis and Lack of Awareness

Ocular hypertension is often a silent condition, with no obvious symptoms, making it challenging to detect early. Many individuals are unaware of the condition and its potential progression to glaucoma, which leads to a delay in diagnosis and intervention. This lack of awareness poses a significant barrier to market growth, as untreated ocular hypertension can advance to glaucoma, resulting in irreversible vision loss. Public ignorance about the importance of regular eye check-ups further complicates early detection efforts. Raising awareness about ocular hypertension and its connection to glaucoma is essential for capturing potential patients early, when treatments are most effective. Healthcare professionals, ophthalmologists, and public health campaigns must play a key role in educating individuals about the risks of ocular hypertension and the need for proactive eye care.

Key Market Trends:

Minimally Invasive Surgical Techniques

Minimally invasive surgical techniques are transforming the treatment landscape for ocular hypertension. Traditionally, managing elevated intraocular pressure involved more invasive surgeries, often with longer recovery times and higher risks. However, the development of Micro-Invasive Glaucoma Surgery (MIGS) has introduced a less invasive approach that reduces surgical trauma while targeting the underlying causes of elevated intraocular pressure. MIGS has numerous benefits for both patients and healthcare providers, including shorter recovery periods, lower complication rates, and improved patient outcomes. The growing adoption of MIGS is expected to continue driving the ocular hypertension treatment market, providing a shift toward more efficient and patient-friendly treatment options.

Key Market Players:

• Angelini Spa
• Laboratorios Sophia
• Neurim Pharmaceuticals Ltd
• Nicox SA
• Novartis AG
• Aerie Pharmaceuticals, Inc.
• AbbVie, Inc.
• Angelini Pharma S.p.a.
• Chong Kun Dang Pharmaceutical Corp
• Lee Pharma Ltd

Report Scope:

This report segments the global ocular hypertension treatment market into various categories and provides a detailed analysis of trends:

By Type:

• Intraocular Hypertension
• Glaucoma

By Route of Administration:

• Oral
• Parenteral
• Other

By Distribution Channel:

• Retail Pharmacy
• Online Pharmacy
• Other

By Region:

• North America: United States, Canada, Mexico
• Europe: France, United Kingdom, Italy, Germany, Spain
• Asia-Pacific: China, India, Japan, Australia, South Korea
• South America: Brazil, Argentina, Colombia
• Middle East & Africa: South Africa, Saudi Arabia, UAE

Competitive Landscape:

This section provides a comprehensive analysis and profiling of major companies operating in the global ocular hypertension treatment market.

Available Customizations:

TechSci Research offers tailored customization options for this market report, allowing adjustments to meet specific company needs. Customization options include detailed analysis and profiling of up to five additional market players.

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Ocular Hypertension Treatment Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Type (Intraocular Hypertension, Glaucoma)
  • 4.2.2. By Route Of Administration (Oral, Parenteral, Other)
  • 4.2.3. By Distribution Channel (Retail Pharmacy, Online Pharmacy, Other)
  • 4.2.4. By Region
  • 4.2.5. By Company (2024)
• 4.3. Market Map
  • 4.3.1. By Type
  • 4.3.2. By Route Of Administration
  • 4.3.3. By Distribution Channel
  • 4.3.4. By Region

5. Asia Pacific Ocular Hypertension Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type
  • 5.2.2. By Route Of Administration
  • 5.2.3. By Distribution Channel
  • 5.2.4. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Ocular Hypertension Treatment Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Type
      • 5.3.1.2.2. By Route Of Administration
      • 5.3.1.2.3. By Distribution Channel
  • 5.3.2. India Ocular Hypertension Treatment Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Type
      • 5.3.2.2.2. By Route Of Administration
      • 5.3.2.2.3. By Distribution Channel
  • 5.3.3. Australia Ocular Hypertension Treatment Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Type
      • 5.3.3.2.2. By Route Of Administration
      • 5.3.3.2.3. By Distribution Channel
  • 5.3.4. Japan Ocular Hypertension Treatment Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Type
      • 5.3.4.2.2. By Route Of Administration
      • 5.3.4.2.3. By Distribution Channel
  • 5.3.5. South Korea Ocular Hypertension Treatment Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Type
      • 5.3.5.2.2. By Route Of Administration
      • 5.3.5.2.3. By Distribution Channel

6. Europe Ocular Hypertension Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Route Of Administration
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Ocular Hypertension Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Route Of Administration
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Germany Ocular Hypertension Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Route Of Administration
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Spain Ocular Hypertension Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Route Of Administration
      • 6.3.3.2.3. By Distribution Channel
  • 6.3.4. Italy Ocular Hypertension Treatment Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Type
      • 6.3.4.2.2. By Route Of Administration
      • 6.3.4.2.3. By Distribution Channel
  • 6.3.5. United Kingdom Ocular Hypertension Treatment Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Type
      • 6.3.5.2.2. By Route Of Administration
      • 6.3.5.2.3. By Distribution Channel

7. North America Ocular Hypertension Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Route Of Administration
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Ocular Hypertension Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Route Of Administration
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. Mexico Ocular Hypertension Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Route Of Administration
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. Canada Ocular Hypertension Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Route Of Administration
      • 7.3.3.2.3. By Distribution Channel

8. South America Ocular Hypertension Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Route Of Administration
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Ocular Hypertension Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Route Of Administration
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. Argentina Ocular Hypertension Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Route Of Administration
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Colombia Ocular Hypertension Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Route Of Administration
      • 8.3.3.2.3. By Distribution Channel

9. Middle East and Africa Ocular Hypertension Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Route Of Administration
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Ocular Hypertension Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Route Of Administration
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. Saudi Arabia Ocular Hypertension Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Route Of Administration
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. UAE Ocular Hypertension Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Route Of Administration
      • 9.3.3.2.3. By Distribution Channel

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Ocular Hypertension Treatment Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Angelini Spa
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. SWOT Analysis
• 14.2. Laboratorios Sophia
• 14.3. Neurim Pharmaceuticals Ltd
• 14.4. Nicox SA
• 14.5. Novartis AG.
• 14.6. Aerie Pharmaceuticals, Inc.
• 14.7. Abbvie, Inc
• 14.8. Angelini Pharma S.p.a.
• 14.9. Chong Kun Dang pharmaceutical Corp
• 14.10. Lee Pharma Ltd

15. Strategic Recommendations

16. About Us & Disclaimer